Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mason Research Institute appears to have been a U.S.-based life sciences research organization rather than a drug-development biotech company. Historical records indicate that it operated in Worcester, Massachusetts and later as EG&G Mason Research Institute, with capabilities in immunoassay, immunogenetics, monoclonal antibodies, and in vivo drug and biological response modifier testing. The organization also performed contract R&D work for government and institutional clients, and its current public-facing website reflects broader engineering and research contracting activities rather than a biopharma pipeline. Available evidence suggests the historical corporate entity EG&G Mason Research Institute, Inc. is dissolved, and no current therapeutic pipeline, clinical programs, or commercial drug assets could be verified. Because the requested name maps to a sparse and somewhat ambiguous historical entity, several fields below are left null or empty where no reliable current evidence was found.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mason Research Institute.